Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the pepper-study

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Pabst, Stefan ^a   Hammerstingl, Christoph ^a   Hundt, Felix ^a   Gerhardt, Thomas ^b   Grohé, Christian ^c   Nickenig, Georg ^a   Woitas, Rainer ^a   Skowasch, Dirk ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Gemeinschaftspraxis für Nieren und Hochdruckkrankheiten   (Germany)

^c The Lungenklinik Berlin Buch   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEART CATHETERIZATION; HEMODIALYSIS; HUMAN; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS;

EID: 84859975593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035310     Document Type: Article

References (22)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047.
2. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, et al. (2003) Pulmonary hypertension in patients with end-stage renal disease. Chest 123: 1577-1582.
3. Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, et al. (2007) Pulmonary hypertension in patients with chronic renal failure. Respiration 74: 503-510.
4. Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, et al. (2009) Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc 41: 2753-2756.
5. Ramasubbu K, Deswal A, Herdejurgen C, Aguilar D, Frost AE, A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med 2010;3: 279-286.
6. Abdelwhab S, Elshinnawy S, Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 2008;28: 990-997.
7. Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, et al. (2009) Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 75: 969-975.
8. Galié N, Hoeper MM, Humbert M, Torbicki A, et al. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT) (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34: 1219-1263.
9. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, et al. (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54 (1 Suppl): S43-S54.
10. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, et al. (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173: 1023-1030.
11. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification (2002) Am J Kidney Dis 39 (suppl. 1): S1-S266.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
13. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, et al. (2000) Abnormalities of endothelial function in patients with pre-dialysis renal failure. Heart 83: 205-209.
14. Arese M, Strasly M, Ruva C, Costamagna C, Ghigo D, et al. (1995) Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 10: 1386-1397.
15. Aznar-Salatti J, Escolar G, Cases A, Gómez-Ortiz G, Anton P, et al. (1995) Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix. Nephrol Dial Transplant 10: 2199-2204.
16. Stefanidis I, Wurth P, Mertens PR, Ikonomov V, Philippidis G, et al. (2004) Plasma endothelin-1 in hemodialysis treatment- the influence of hypertension. J Cardiovasc Pharmacol 44 (Suppl 1): S43-S48.
17. Odetti P, Monacelli F, Storace D, Robaudo C, Rossi S, et al. (2006) Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. Horm Metab Res 38: 817-820.
18. Tomić M, Galesić K, Markota I, (2008) Endothelin-1 and nitric oxide in patients on chronic hemodialysis. Ren Fail 30: 836-842.
19. El-Shafey EM, El-Nagar GF, Selim MF, El-Sorogy HA, Sabry AA, (2008) Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis? Clin Exp Nephrol 12: 370-375.
20. Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z, (2005) The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 20: 1686-1692.
21. Unal A, Tasdemir K, Oymak S, Duran M, Kocyigit I, et al. (2010) The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients. Hemodial Int 14: 398-402.
22. Liefeldt L, van Giersbergen PLM, Dingemanse J, Rudolph B, Walde T, et al. (2004) Treatment of secondary pulmonary hypertension with Bosentan and its pharmacokinetic monitoring in ESRD. Am J Kidney Dis 43: 923-926.